These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1983098)

  • 1. Synergy between activated Leishmania major-specific CD4+ T lymphocytes and bone-marrow-derived cells in the exacerbation of murine cutaneous leishmaniasis.
    Mendonça SC; Titus RG; Louis JA
    Res Immunol; 1990; 141(9):865-78. PubMed ID: 1983098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W
    Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity.
    Titus RG; Müller I; Kimsey P; Cerny A; Behin R; Zinkernagel RM; Louis JA
    Eur J Immunol; 1991 Mar; 21(3):559-67. PubMed ID: 1672641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.
    Müller I; Pedrazzini T; Kropf P; Louis J; Milon G
    Int Immunol; 1991 Jun; 3(6):587-97. PubMed ID: 1909563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
    Alexander J; Kaye PM
    Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.
    Dhaliwal JS; Liew FY
    Infect Immun; 1987 Mar; 55(3):645-51. PubMed ID: 3818088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma inhibits the efficacy of interleukin 1 to generate a Th2-cell biased immune response induced by Leishmania major.
    Wagner HM; Beuscher HU; Röllinghoff M; Solbach W
    Immunobiology; 1991 Jun; 182(3-4):292-306. PubMed ID: 1680802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
    J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania major: nature of immunity induced by immunization with a mutagenized avirulent clone of the parasite in mice.
    McGurn M; Boon T; Louis JA; Titus RG
    Exp Parasitol; 1990 Jul; 71(1):81-9. PubMed ID: 1972362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning.
    Probst P; Stromberg E; Ghalib HW; Mozel M; Badaro R; Reed SG; Webb JR
    J Immunol; 2001 Jan; 166(1):498-505. PubMed ID: 11123329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.
    Scott P; Natovitz P; Coffman RL; Pearce E; Sher A
    J Exp Med; 1988 Nov; 168(5):1675-84. PubMed ID: 2903212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania major-specific, CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice.
    Shankar AH; Titus RG
    J Exp Med; 1993 Jul; 178(1):101-11. PubMed ID: 7686209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of antigen-specific TH1 and TH2 cells in genetically susceptible BALB/c mice infected with Leishmania major.
    Lohoff M; Sommer F; Solbach W; Röllinghoff M
    Immunobiology; 1989 Oct; 179(4-5):412-21. PubMed ID: 2575598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
    Doherty TM; Coffman RL
    J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.
    Hill JO
    Immunology; 1991 Feb; 72(2):282-6. PubMed ID: 1826673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.